| Federal Response Blog Posts | |
| Vaginal Ring for HIV Prevention Receives Positive Opinion from European Regulator | |
| Today the European Medicines Agency (EMA) announced it has adopted a positive scientific opinion on the dapivirine vaginal ring for use by cisgender women ages 18 and older in developing countries to reduce their risk of HIV infection. | |
| |
| Kidney Transplantation Between People with HIV is Safe, NIH Study Finds | |
| Kidney transplantation from deceased donors with HIV to people living with both HIV and end-stage kidney disease is feasible and safe, investigators supported by the National Institutes of Health have found. Their study demonstrates that the pool of available kidneys for people with HIV can be expanded by including donors with HIV, making more kidneys available for all who are awaiting a transplant. | |
|
| AHEAD Dashboard: Understanding the Sources of EHE Indicator Data | |
| Ending the HIV Epidemic (EHE) is a whole-of-society initiative to end the HIV epidemic in the U.S. When America’s HIV Epidemic Analysis Dashboard (AHEAD) is launched next month, it will graphically visualize data on the six EHE HIV indicators for the 57 jurisdictions prioritized in the federal initiative. The data for the nation and phase 1 jurisdictions visualized on AHEAD will be our starting point for measuring progress toward ending the HIV epidemic in the U.S. | |
|
| “Live with Leadership” Conversations Videos Now Available | |
| During AIDS 2020, HIV.gov held three opportunities for attendees to hear directly from key HHS leaders about current and planned activities to further Ending the HIV Epidemic: A Plan for America (EHE). At each of the 20-minute sessions, participants heard short remarks from either CDC’s Dr. Jono Mermin, HRSA’s Dr. Laura Cheever, or Mr. Harold Phillips, from the Office of Infectious Disease and HIV/AIDS Policy. The presenters then answered questions about EHE from the virtual audience. | |
|
| NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment | |
| The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and IAVI, a nonprofit scientific research organization, recently announced a collaboration to develop combinations of HIV broadly neutralizing antibodies (bNAbs) that could be produced on a large scale at low cost to prevent and possibly treat HIV. | |
|
.png)
No hay comentarios:
Publicar un comentario